End-of-day quote
Other stock markets
|
||
- | - |
Apr. 25 | Labcorp beats quarterly estimates on strong testing demand | RE |
Apr. 25 | Clinical lab operator Labcorp to buy bankrupt genetic test maker Invitae for $239 mln | RE |
Sales 2021 | 460M 0 | Sales 2022 | 516M 0 | Capitalization | 452M 0 |
---|---|---|---|---|---|
Net income 2021 | -379M - | Net income 2022 | -3.11B - | EV / Sales 2021 | 8.98 x |
Net Debt 2021 | 679M 0 | Net Debt 2022 | 1.2B 0 | EV / Sales 2022 | 3.21 x |
P/E ratio 2021 |
-8.5
x | P/E ratio 2022 |
-0.14
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 98.19% |
Latest transcript on InVitae Corp
Managers | Title | Age | Since |
---|---|---|---|
Kenneth Knight
CEO | Chief Executive Officer | 63 | 20-06-28 |
Ana Schrank
DFI | Director of Finance/CFO | - | 23-10-01 |
David Sholehvar
COO | Chief Operating Officer | 56 | Nov. 12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 67 | 15-11-03 | |
Randal Scott
CEO | Chief Executive Officer | 66 | 10-01-12 |
Eric Aguiar
BRD | Director/Board Member | 62 | 10-08-31 |
1st Jan change | Capi. | |
---|---|---|
-27.07% | 9.96B | |
-8.28% | 3.03B | |
+35.24% | 3B | |
-14.73% | 2.18B | |
-14.50% | 1.76B | |
+66.34% | 1.42B | |
+25.62% | 794M | |
-2.18% | 756M | |
+3.18% | 305M |